Medical Marijuana Patients Report Sustained Relief From GI Symptoms Over One Year

Patients with chronic gastrointestinal symptoms who used medical marijuana reported significant decreases in symptom severity at every time point over 12 months.

Wallingford, Matthew P et al.·Medical cannabis and cannabinoids·2024·Preliminary EvidenceObservational
RTHC-05793ObservationalPreliminary Evidence2024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Observational
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

At each survey (baseline, 30 days, 6 months, 12 months), participants reported significantly lower GI symptom severity when using medical marijuana versus when not using it (p < 0.05 at every time point).

Key Numbers

Significant symptom severity decrease at all four time points (p < 0.05). Most common side effects: increased appetite (12-21.4%), fatigue (6-16.7%), anxiety (4-11.9%), cough (4-11.9%), headache (6-7.9%), dry mouth (4-7.1%).

How They Did This

Longitudinal observational study following medical marijuana patients who completed surveys at baseline, 30 days, 6 months, and 12 months. GI symptom severity was self-rated on a 1 (mild) to 3 (severe) scale. Side effects were also tracked.

Why This Research Matters

Chronic GI conditions like IBS and Crohn's disease are notoriously difficult to manage. This 12-month follow-up provides some of the first evidence that medical marijuana's benefits for GI symptoms persist over time rather than diminishing with continued use.

The Bigger Picture

The endocannabinoid system is densely distributed throughout the gut and plays a role in motility, inflammation, and pain signaling. These patient-reported improvements align with preclinical evidence that cannabinoids modulate gastrointestinal function through multiple pathways.

What This Study Doesn't Tell Us

Self-reported outcomes without a placebo control group make it impossible to separate the pharmacological effects of marijuana from placebo effects or natural symptom fluctuation. No standardized GI diagnosis was required for enrollment. The simple 3-point severity scale limits granularity.

Questions This Raises

  • ?Which specific GI conditions respond best to medical marijuana?
  • ?Do different cannabis formulations (high-THC vs high-CBD vs balanced) produce different GI outcomes?

Trust & Context

Key Stat:
Significant GI symptom improvement at all 4 time points over 12 months (p < 0.05)
Evidence Grade:
Preliminary: longitudinal self-reported data over 12 months shows consistency, but lacks placebo control, objective measures, and specific diagnoses.
Study Age:
2024 study.
Original Title:
Relief in Gastrointestinal Symptoms with Medical Marijuana Over 1 Year.
Published In:
Medical cannabis and cannabinoids, 7(1), 80-85 (2024)
Database ID:
RTHC-05793

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Watches what happens naturally without intervening.

What do these levels mean? →

Frequently Asked Questions

Did the relief wear off over time?

No. Participants reported significant symptom improvement at every time point measured -- 30 days, 6 months, and 12 months -- suggesting the benefits persisted rather than diminishing.

What were the most common side effects?

Increased appetite (up to 21%), fatigue (up to 17%), anxiety (up to 12%), and cough (up to 12%) were the most frequently reported side effects over the study period.

Read More on RethinkTHC

Cite This Study

RTHC-05793·https://rethinkthc.com/research/RTHC-05793

APA

Wallingford, Matthew P; Kelly, Erin L; Herens, Allison; Hanna, Daniel; Hajjar, Emily; Worster, Brooke. (2024). Relief in Gastrointestinal Symptoms with Medical Marijuana Over 1 Year.. Medical cannabis and cannabinoids, 7(1), 80-85. https://doi.org/10.1159/000538694

MLA

Wallingford, Matthew P, et al. "Relief in Gastrointestinal Symptoms with Medical Marijuana Over 1 Year.." Medical cannabis and cannabinoids, 2024. https://doi.org/10.1159/000538694

RethinkTHC

RethinkTHC Research Database. "Relief in Gastrointestinal Symptoms with Medical Marijuana O..." RTHC-05793. Retrieved from https://rethinkthc.com/research/wallingford-2024-relief-in-gastrointestinal-symptoms

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.